AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective lifted by equities research analysts at BTIG Research from $56.00 to $68.00 in a research report issued to clients and investors on Wednesday, FlyOnTheWall reports. BTIG Research’s price objective points to a potential upside of 17.79% from the stock’s current price. A number of other […]
AtriCure (NASDAQ:ATRC – Get Free Report) updated its FY23 earnings guidance on Tuesday. The company provided EPS guidance of $(0.94)-(0.92) for the period, compared to the consensus EPS estimate of ($0.99). The company issued revenue guidance of $392-395 million, compared to the consensus revenue estimate of $388.40 million. AtriCure Price Performance ATRC traded down $0.15 […]
BTIG Research Boosts AtriCure (NASDAQ:ATRC) Price Target to $56 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
CM Wealth Advisors LLC bought a new stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in the first quarter, Holdings Channel.com reports. The institutional investor bought 9,924 shares of the medical device company’s stock, valued at approximately $419,000. A number of other hedge funds also recently modified their holdings of the business. SG Americas Securities […]
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) saw a significant decline in short interest during the month of June. As of June 30th, there was short interest totalling 1,140,000 shares, a decline of 22.4% from the June 15th total of 1,470,000 shares. Based on an average daily trading volume, of 266,700 shares, the days-to-cover ratio […]